Showing results (41-50 of 53) with videos related to
Sort By:
Pageof 6
Clinical and Experimental Immunology|August 1, 1987
Quantitative evaluation of the terminal C5b-9 complement complex by ELISA in human atherosclerotic arteriesF Niculescu, F Hugo, H G Rus, et al.Medecine Interne|October 1, 1983
Immunologic alterations associated with chronic hemodialysisH G Rus, A Cristea, M Gherman, et al.Immunology Letters|March 1, 1989
Cells carrying C5b-9 complement complexes in human atherosclerotic wallH G Rus, F Niculescu, D Poruţiu, et al.Atherosclerosis|July 1, 1986
Immunoelectron-microscopic localization of the terminal C5b-9 complement complex in human atherosclerotic fibrous plaqueH G Rus, F Niculescu, E Constantinescu, et al.Medecine Interne|April 1, 1988
Lupus anticoagulant and transient severe bleeding tendency in a girl aged nine yearsM Nanulescu, I Trif, M Cucuianu, et al.Thrombosis Research|June 1, 1983
Comparative behaviour of the components of the factor VIII complex in acute myocardial infarctionM P Cucuianu, A Cristea, S Roman, et al.The Journal of Biological Chemistry|October 3, 1998
Molecular cloning and characterization of RGC-32, a novel gene induced by complement activation in oligodendrocytesT C Badea, F I Niculescu, L Soane, et al.Archives Roumaines De Pathologie Experimentales Et De Microbiologie|July 1, 1989
Isolation of anti-carcinoembryonic antigen (CEA), specific immunoglobulins and their use in immunocytochemical and enzyme-immunoassays (ELISA)F Niculescu, H G Rus, D Ionescu, et al.Clinica Chimica Acta; International Journal of Clinical Chemistry|April 30, 1985
Clinical studies on plasma fibronectin and factor XIII; with special reference to hyperlipoproteinemiaM Cucuianu, H G Rus, A Cristea, et al.Thrombosis and Haemostasis|April 25, 1989
Tissue-type plasminogen activator (t-PA) and dilute blood clot lysis time in nephrotic patientsM P Cucuianu, H G Rus, S Roman, et al.Pageof 6